Torsdag 5 Juni | 23:34:20 Europe / Stockholm

Prenumeration

2025-06-02 09:40:00

Antimicrobial resistance poses a rising threat to global health. Countering this threat head-on, Oslo-based AdjuTec Pharma is developing compounds that restore the potency of existing antibiotics. The goal is to pioneer a new era in antibiotic rescue therapy. We spoke with CEO Jethro Holter and his team to learn more.

Read the full interview at biostock.se:

https://biostock.se/en/2025/06/rearming-antibiotics-adjutec-pharmas-fight-against-antimicrobial-resistance/
 
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/